Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Oxford Immunotec raises $40 million

Diagnostic company Oxford Immunotec (Oxford, U.K.) raised $40

Read the full 86 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE